Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vascular gene therapy

M Y Flugelman1

  • 1Department of Cardiology, Lady Davis Carmel Medical Center, Haifa, Israel.

Advances in Experimental Medicine and Biology
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Gene therapy shows promise for cardiovascular diseases. Adenoviral vectors efficiently delivered genes to vascular cells, a key step for developing new treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Co-expression of fibulin-5 and VEGF165 increases long-term patency of synthetic vascular grafts seeded with autologous endothelial cells.

Gene therapy·2015
Same author

Fibulin-5 regulates keloid-derived fibroblast-like cells through integrin beta-1.

International journal of cosmetic science·2015
Same author

The formation of an anti-restenotic/anti-thrombotic surface by immobilization of nitric oxide synthase on a metallic carrier.

Acta biomaterialia·2014
Same author

High frequency of vitamin B12 deficiency in asymptomatic individuals homozygous to MTHFR C677T mutation is associated with endothelial dysfunction and homocysteinemia.

American journal of physiology. Heart and circulatory physiology·2007
Same author

Effects of fibulin-5 on attachment, adhesion, and proliferation of primary human endothelial cells.

Biochemical and biophysical research communications·2006
Same author

Thrombolysis in patients with a brain tumour.

Heart (British Cardiac Society)·2004
Same journal

Mammalian Respiratory Chain Complex Assemblies and Their Links to Mitochondria Stress-Induced Human Diseases.

Advances in experimental medicine and biology·2026
Same journal

Enzyme Assemblies in Nucleotide Metabolism: Structure, Regulation, and Disease Implications.

Advances in experimental medicine and biology·2026
Same journal

The Pyruvate Dehydrogenase Complex: A 90-Year-Old Enigma Shaping the Future of Structural Enzymology.

Advances in experimental medicine and biology·2026
Same journal

Regulation of the Anti-termination RNA Transcription Complex by Lon-Mediated Lambda N Degradation.

Advances in experimental medicine and biology·2026
Same journal

PCNA Macromolecular Complexes: PCNA Serves as a Molecular Hub Regulating Multiple Cellular Processes Inside and Outside of the Nucleus.

Advances in experimental medicine and biology·2026
Same journal

Dynamic Assemblies in Genome Maintenance.

Advances in experimental medicine and biology·2026
See all related articles

Area of Science:

  • Cardiovascular Research
  • Gene Therapy
  • Biomedical Engineering

Background:

  • Cardiovascular diseases remain a leading cause of mortality worldwide.
  • Gene therapy offers a novel approach to treating cardiovascular pathologies.
  • Endothelial cell seeding of prostheses is a potential strategy for vascular repair.

Purpose of the Study:

  • To investigate the use of genetically engineered endothelial cells for seeding endovascular prostheses.
  • To evaluate cell adhesion to prostheses in vitro and in vivo.
  • To assess the efficiency of gene transfer to arterial wall cells using different viral vectors.

Main Methods:

  • Genetically engineered endothelial cells were used to seed endovascular prostheses.
  • Cell adhesion was tested using in vitro and in vivo models.

Related Experiment Videos

  • Catheter-based systems delivered genes via retroviral and adenoviral vectors to arterial wall cells.

    • Main Results:

    • Successful seeding of endovascular prostheses with genetically engineered endothelial cells.
    • Demonstrated cell adhesion to prostheses in both in vitro and in vivo settings.
    • Achieved efficient gene transfer to vascular cells in vivo, particularly with adenoviral vectors.

    Conclusions:

    • Gene therapy holds significant potential as a therapeutic strategy for cardiovascular conditions.
    • Adenoviral vectors are effective for in vivo gene transfer to vascular cells.
    • This research supports the development of advanced gene therapy approaches for cardiovascular repair.